X-ray crystallography provides a time and ensembleaveraged picture of a protein's three-dimensional structure. An individual molecule in solution, however, constantly fluctuates among many conformational substates in a complex energy landscape (Frauenfelder et al. 1991) . That the resulting ''structural dynamics'' is essential for biological activity is evident in the process of ligand binding. Indeed, in many cases only a conformational change permits accommodation of a ligand, in contrast to the classical lock-and-key mechanism, in which the two rigid binding partners are of complementary shape. Two mechanisms have been offered to rationalize conformational changes upon ligand binding, i.e., induced-fit (Koshland 1958) and preexisting equilibrium dynamics (Monod et al. 1965; Tsai et al. 1999 ). In the former, binding of a ligand induces, and thus precedes, the conformational change, whereas in the latter it binds to a specific preexisting conformation already present in the set of conformational substates accessed by equilibrium dynamics. The difference is subtle but might be a crucial issue in structure-based drug design (Steuber et al. 2007) . Here, we 6 These authors contributed equally to this work. 7 compare the repertoire of crystallographic structures of the enzyme acetylcholinesterase (AChE), complexed with various ligands, with conformations accessed by native AChE in molecular dynamics (MD) simulations in order to explore the origin of conformational changes involved in ligand binding.
The main role of AChE is rapid hydrolysis of the neurotransmitter acetylcholine (ACh) (Silman and Sussman 2005) . The crystal structure of Torpedo californica (Tc) AChE (Sussman et al. 1991) showed its active site to be near the bottom of a narrow, 20 Å deep gorge, containing a catalytic triad and a conserved Trp, Trp84, which is the main residue of the catalytic anionic site (CAS) (Fig. 1) . A second Trp, Trp279, is the major residue in the ''peripheral'' anionic site (PAS), at the gorge mouth, which may serve as a relay station for incoming substrate and interact allosterically with the active site (Rosenberry et al. 2005) . A variety of ligands bind to AChE, including first-generation anti-Alzheimer drugs, organophosphorous (OP) nerve agents, and OP and carbamate insecticides (Silman and Sussman 2005) . In most cases, no conformational change is observed in Trp279 upon binding. However, certain bifunctional inhibitors, bridging the CAS and PAS, induce drastic conformational changes in Trp279 and in the equivalent residue of AChEs from other species (Bourne et al. 2004; Colletier et al. 2006; Ekstrom et al. 2006; Rydberg et al. 2006) . Such inhibitors are being developed as potential second-generation antiAlzheimer drugs (Du and Carlier 2004) and as reactivators after OP poisoning (Ekstrom et al. 2006 ).
Here we addressed the issue of whether conformational changes in the PAS Trp are due to induced fit or to selection of a preexisting conformation by comparing conformations accessed in MD simulations with those seen in crystal structures. Some of the side-chain conformations of this residue in crystallographic AChE-ligand complexes, which differ from that in native AChE, are already accessed in a MD simulation of native AChE. Certain conformational changes upon ligand binding thus involve preexisting equilibrium dynamics. Others are suggested to involve induced fit only, or both preexisting equilibrium dynamics and induced fit. Structure-based drug design might thus benefit from the equilibrium conformations in MD simulations of the native enzyme since they are shown to be validated by those seen in crystallographic complexes.
Results and Discussion
Hydrated MD studies were carried out over 20 ns, starting from the native TcAChE structure (PDB ID code 1ea5). The x 1 and x 2 angles defining Trp279's side-chain conformation were recorded at 1-ps intervals ( Fig. 2A) . A broad conformational space is sampled in this simulation, consisting of five islands of distinct conformations.
Comparison with the Trp279 conformations of 89 published crystal structures of AChEs from various species (Table 1) , either native or complexed with ligands, reveals that several experimentally determined conformations are within the five islands accessed in the simulation ( Fig. 2A) . The largest number (groups a-c in Fig. 2A ) are close to those in native AChEs. Ligands binding to the conformations in groups a-c either do not interact with Trp279 directly or involve a lock-and-key mechanism. Those that differ markedly from the native conformation (groups d-g) are mostly of bifunctional inhibitor complexes. Only some mAChE complexes with oxime reactivators (Ekstrom et al. 2006 ) (group e) contain a PAS Trp conformation not accessed in the simulation trajectory, and conformational changes are thus most likely generated by an induced-fit mechanism. The PAS Trp conformations observed in the crystal structures of groups d, f, and g are present in the preexisting equilibrium dynamics of AChE and are selected, and thus accumulate, during ligand binding. If, in contrario, they had been created primarily by induced fit, we would not expect them to be accessed in the MD simulation of native AChE, as is indeed the case for those in group e. Conformations in groups d and f are at the margins of MD islands and may contain both preexisting equilibrium dynamics and a small induced-fit component during ligand binding. We note that a single 20-ns MD simulation might not sample the conformational space of a side chain fully. It is striking, however, that a standard x 1 ,x 2 rotomer plot of tryptophan (Laskowski et al. 1993) Figure 1. 3D structure of native TcAChE (PDB access code 1ea5). Catalytic-triad residues are in red, the active-site gorge in green, and PAS Trp279 and CAS Trp84 in blue.
would miss several of these regions, in particular group f (Fig. 2B) .
More than one of the seven conformational groups (a-g) are accessed in crystalline structures of a given space group (Table 1) . Thus, complexes of a trigonal crystal form (P3 1 21) of TcAChE display Trp279 conformations in groups a, c, and f. Consequently, differences in crystal packing in the different space groups are not at the origin of the differences in conformations of groups a-g. However, the number of accessible Trp279 conformations for a particular space group might be restricted.
AChE is well suited to addressing the origin of conformational changes upon ligand binding, since a large number of crystallographic complexes are available for The space group is given in brackets. The PDB codes of the native AChE data sets are highlighted in bold italics. The corresponding residue number of W279 in each species is shown. The superscripts indicate the group (a-g) to which each conformation belongs in Figure 2. analysis. Our results for AChE suggest that the equilibrium dynamics of native proteins, as monitored by MD simulations, indeed encompass preexisting side-chain conformations selected by ligands. Rational drug design, based on structural information, might profit by taking into account conformational heterogeneity observed in MD simulations. In particular, we suggest that docking assays be performed starting from several protein structures in which amino acids involved in ligand binding are in the various conformations displayed in the MD simulations. Ligands that might not bind to the (average) native protein structure, but rather to a minor conformation in the preexisting equilibrium dynamics, could thus be identified. Binding of ligands contacting several sites simultaneously may involve aspects of preexisting equilibrium dynamics, induced-fit, and lock-and-key mechanisms. Thus, some bifunctional AChE inhibitors (Bourne et al. 2004; Colletier et al. 2006; Ekstrom et al. 2006; Rydberg et al. 2006 ) select a preexisting conformation at the PAS but bind with only minor concomitant conformational changes at the CAS, where they fit in a lock-and-key manner. Rational drug design should thus be based upon both structure and structural dynamics. In this context, structural information from NMR ensembles can also benefit structure-based drug design (Damm and Carlson 2007) .
Preexisting equilibrium dynamics is also involved in protein-protein interactions (Goh et al. 2004) , being capable of conferring multi-specificity upon antibodies in which different preexisting conformations recognize different antigens (James et al. 2003) . Evidence is thus growing that a protein's conformational diversity is essential for a wide range of biological functions. X-ray crystallography, together with other biophysical techniques, can thus add a dynamical dimension to the structural insight it provides, and validate conformational sampling from MD simulations.
Materials and Methods

MD simulation
A monomer of native TcAChE, determined at 1.8 Å resolution (Sussman et al. 1991) , served as the starting structure for simulation (PDB code: 1ea5) . The protein, together with crystal water molecules, was inserted into a box of dimensions 10.6 3 10.6 3 10.6 nm 3 , with the minimal distance of the protein from its walls being 2.0 nm. This box was solvated by use of a simple point charge (SPC) water model (Berendsen et al. 1981 ). The solvated box was then submitted to energy minimization. Subsequently, counter ions were added, so as to provide a neutral simulation system. Energy minimization was then repeated on the whole system. After convergence had been reached, the solvent, the counter ions, and the protein were coupled separately to a temperature bath at 300 K. The whole system was then equilibrated for 20 ns. The final root mean square deviations (RMSDs) of Ca atoms and of all protein atoms are 2.0 and 2.6 Å , respectively, relative to the crystallographic starting structure. The Ramachandran plot of phi/psi angles, however, shows no increase in ''outliers'' relative to the native structure. The time evolution of the Trp279 conformation during the 20-ns simulation is shown in Figure 3 .
MD simulations were carried out with a GROMACS package (Berendsen et al. 1995; Lindahl et al. 2001) , using NPT and periodic boundary conditions. The GROMOS96 force field (van Gunsteren et al. 1996) was applied to the protein. The pressure was kept constant at 1 bar by coupling to a Berendsen barostat with t p ¼ 1.0 ps and a compressibility of 4.5 3 10 À5 bar (Berendsen et al. 1984) . The temperature was maintained at 300 K by coupling to a Berendsen thermostat with a coupling time of t T ¼ 0.1 ps (Berendsen et al. 1984) . The LINCS method (Hess et al. 1997 ) was used to restrain bond lengths, allowing an integration step of 2 fs. The coordinates of the whole system were saved every 500 steps. Electrostatic interactions were calculated using the Particle-Mesh Ewald (PME) algorithm (Darden et al. 1993; Essmann et al. 1995) .
Crystallographic data
Currently, 97 crystal structures of AChE are available from the PDB. The majority are for TcAChE (55 structures) and mAChE (34 structures), as well as two, three, and three structures, respectively, for human, Electrophorus, and Drosophila AChE. Of the nine radiation-damaged native TcAChE structures (Weik et al. 2000) , only one, i.e., 1qid, was selected. Thus, 89 crystal structures are used for the x 1 and x 2 angles analysis of W279. The PDB codes of the 89 structures are listed in Table 1 and the space group of the corresponding crystal form is given. Figure 2A . Khaki: island containing crystallographic groups a and b; blue: island containing group c; cyan: island containing group d; gray: island containing group f; mauve: island containing group g. M.W. from the Agence Nationale de la Recherche (project number JC05_45685), from the NIH CounterACT Program, the US Army Defense Threat Reduction Agency, the Nalvyco Foundation, the Kimmelman Center for Biomolecular Structure and Assembly, and the Minerva Foundation to J.L.S.; from the Benoziyo Center for Neuroscience to I.S.; and from the Israel Structural Proteomics Center (ISPC), supported by the Israel Ministry of Science, Culture and Sport, the Divadol Foundation, and the European Commission VIth Framework ''SPINE2-COMPLEXES'' Project. J.P.C. was supported by an EMBO short-term fellowship. J.L.S. holds the Morton and Gladys Pickman Chair of Structural Biology.
